Current Hepatitis Reports

, Volume 5, Issue 1, pp 27–32 | Cite as

Natural history of hbeag-negative chronic Hepatitis b



Hepatitis B e antigen (HBeAg)-negative chronic hepatitis B refers to an atypical presentation of chronic hepatitis B characterized by the absence of HBeAg but with clinical and histologic evidence of chronic hepatitis and the presence of ongoing viral replication. It is caused by a variety of mutations affecting transcription and translation of the precore-core RNA, the most common being the precore and double core promoter mutations. They have a worldwide distribution and development of the precore variant is genotype dependent. These variants may present as fulminant hepatitis but more commonly present as asymptomatic hepatitis during the natural course of chronic infection. The most characteristic pattern is one of severe flares followed by remissions. Long-term response to therapy is poor.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Lok AS, McMahon BJ: Chronic hepatitis B. Hepatology 2001, 34:1225–1241. Excellent clinical review of hepatitis B. Outlines American Association for the Study of Liver Diseases guidelines.PubMedCrossRefGoogle Scholar
  2. 2.
    Ganem D, Prince AM: Hepatitis B virus infection—natural history and clinical consequences. N Engl J Med 2004, 350:1118–1129.PubMedCrossRefGoogle Scholar
  3. 3.
    Hadziyannis SJ, Vassilopoulos D: Hepatitis B e antigennegative chronic hepatitis B. Hepatology. 2001, 34(4 Pt 1):617–624 Succinct clinical review of HBeAg-negative CHB, including historical perspectives and therapy.PubMedCrossRefGoogle Scholar
  4. 4.
    Ganem D, Varmus HE: The molecular biology of the hepatitis B viruses. Annu Rev Biochem 1987, 56:651–693.PubMedCrossRefGoogle Scholar
  5. 5.
    Carman WF, Jacyna MR, Hadziyannis S, et al.: Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989, 2:588–591.PubMedCrossRefGoogle Scholar
  6. 6.
    Li JS, Tong SP, Wen YM, et al.: Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region. J Virol 1993, 67:5402–5410.PubMedGoogle Scholar
  7. 7.
    Lok AS, Akarca U, Greene S: Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proc Natl Acad Sci U S A 1994, 91:4077–4081.PubMedCrossRefGoogle Scholar
  8. 8.
    Okamoto H, Yotsumoto S, Akahane Y, et al.: Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 1990, 64:1298–1303.PubMedGoogle Scholar
  9. 9.
    Takeda K, Akahane Y, Suzuki H, et al.: Defects in the precore region of the HBV genome in patients with chronic hepatitis B after sustained seroconversion from HBeAg to anti-HBe induced spontaneously or with interferon therapy. Hepatology 1990, 12:1284–1289.PubMedCrossRefGoogle Scholar
  10. 10.
    Lindh M, Horal P, Dhillon AP, et al.: Hepatitis B virus carriers without precore mutations in hepatitis B e antigen-negative stage show more severe liver damage. Hepatology 1996, 24:494–501.PubMedCrossRefGoogle Scholar
  11. 11.
    Ahn SH, Kramvis A, Kawai S, et al.: Sequence variation upstream of precore translation initiation codon reduces hepatitis B virus e antigen production. Gastroenterology 2003, 125:1370–1378.PubMedCrossRefGoogle Scholar
  12. 12.
    Kidd-Ljunggren K, Oberg M, Kidd AH: Hepatitis B virus X gene 1751 to 1764 mutations: implications for HBeAg status and disease. J Gen Virol 1997, 78(Pt 6):1469–1478.PubMedGoogle Scholar
  13. 13.
    Okamoto H, Tsuda F, Akahane Y, et al.: Hepatitis B virus with mutations in the core promoter for an e antigennegative phenotype in carriers with antibody to e antigen. J Virol 1994, 68:8102–8110.PubMedGoogle Scholar
  14. 14.
    Chan HL, Hussain M, Lok AS: Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion. Hepatology 1999, 29:976–984.PubMedCrossRefGoogle Scholar
  15. 15.
    Funk ML, Rosenberg DM, Lok AS: Worldwide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants. J Viral Hepat 2002, 9:52–61.PubMedCrossRefGoogle Scholar
  16. 16.
    Chan HL, Leung NW, Hussain M, et al.: Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong. Hepatology 2000, 31:763–768.PubMedCrossRefGoogle Scholar
  17. 17.
    Brunetto MR, Giarin MM, Oliveri F, et al.: Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci U S A 1991, 88:4186–4190.PubMedCrossRefGoogle Scholar
  18. 18.
    Rizzetto M, Volpes R, Smedile A: Response of pre-core mutant chronic hepatitis B infection to lamivudine. J Med Virol 2000, 61:398–402.PubMedCrossRefGoogle Scholar
  19. 19.
    Shindo M, Hamada K, Koya S, et al.: The clinical significance of core promoter and precore mutations during the natural course and interferon therapy in patients with chronic hepatitis B. Am J Gastroenterol 1999, 94:2237–2245.PubMedCrossRefGoogle Scholar
  20. 20.
    Milich DR, Jones JE, Hughes JL, et al.: Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci U S A 1990, 87:6599–6603.PubMedCrossRefGoogle Scholar
  21. 21.
    Milich D, Liang TJ: Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 2003, 38:1075–1086. Excellent review of the role of HBeAg in HBV infection.PubMedCrossRefGoogle Scholar
  22. 22.
    Ogata N, Miller RH, Ishak KG, et al.: The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees. Virology 1993, 194:263–276.PubMedCrossRefGoogle Scholar
  23. 23.
    Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen. The Incident Investigation Teams and others [no authors listed]. N Engl J Med 1997, 336:178-184.Google Scholar
  24. 24.
    Terazawa S, Kojima M, Yamanaka T, et al.: Hepatitis B virus mutants with precore-region defects in two babies with fulminant hepatitis and their mothers positive for antibody to hepatitis B e antigen. Pediatr Res 1991, 29:5–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Chang C, Enders G, Sprengel R, et al.: Expression of the precore region of an avian hepatitis B virus is not required for viral replication. J Virol 1987, 61:3322–3325.PubMedGoogle Scholar
  26. 26.
    Chen HS, Kew MC, Hornbuckle WE, et al.: The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host. J Virol 1992, 66:5682–5684.PubMedGoogle Scholar
  27. 27.
    Carman WF, Fagan EA, Hadziyannis S, et al.: Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis. Hepatology 1991, 14:219–222.PubMedGoogle Scholar
  28. 28.
    Raimondo G, Tanzi E, Brancatelli S, et al.: Is the course of perinatal hepatitis B virus infection influenced by genetic heterogeneity of the virus? J Med Virol 1993, 40:87–90.PubMedCrossRefGoogle Scholar
  29. 29.
    Mphahlele MJ, Shattock AG, Boner W, et al.: Transmission of a homogenous hepatitis B virus population of A1896-containing strains leading to mild resolving acute hepatitis and seroconversion to hepatitis B e antigen antibodies in an adult. Hepatology 1997, 26:743–746.PubMedCrossRefGoogle Scholar
  30. 30.
    Liang TJ, Hasegawa K, Rimon N, et al.: A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med 1991, 324:1705–1709.PubMedCrossRefGoogle Scholar
  31. 31.
    Petrosillo N, Ippolito G, Solforosi L, et al.: Molecular epidemiology of an outbreak of fulminant hepatitis B. J Clin Microbiol 2000, 38:2975–2981.PubMedGoogle Scholar
  32. 32.
    Stuyver L, De Gendt S, Cadranel JF, et al.: Three cases of severe subfulminant hepatitis in heart-transplanted patients after nosocomial transmission of a mutant hepatitis B virus. Hepatology 1999, 29:1876–1883.PubMedCrossRefGoogle Scholar
  33. 33.
    Tanaka S, Yoshiba M, Iino S, et al.: A common-source outbreak of fulminant hepatitis B in hemodialysis patients induced by precore mutant. Kidney Int 1995, 48:1972–1978.PubMedCrossRefGoogle Scholar
  34. 34.
    Bahn A, Hilbert K, Martine U, et al.: Selection of a precore mutant after vertical transmission of different hepatitis B virus variants is correlated with fulminant hepatitis in infants. J Med Virol 1995, 47:336–341.PubMedCrossRefGoogle Scholar
  35. 35.
    Fagan EA, Smith PM, Davison F, et al.: Fulminant hepatitis B in successive female sexual partners of two anti-HBepositive males. Lancet 1986, 2:538–540.PubMedCrossRefGoogle Scholar
  36. 36.
    Tur-Kaspa R, Klein A, Aharonson S: Hepatitis B virus precore mutants are identical in carriers from various ethnic origins and are associated with a range of liver disease severity. Hepatology 1992, 16:1338–1342.PubMedCrossRefGoogle Scholar
  37. 37.
    Akarca US, Greene S, Lok AS: Detection of precore hepatitis B virus mutants in asymptomatic HBsAg-positive family members. Hepatology 1994, 19:1366–1370.PubMedGoogle Scholar
  38. 38.
    Sato S, Suzuki K, Akahane Y, et al.: Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med 1995, 122:241–248.PubMedGoogle Scholar
  39. 39.
    Laskus T, Rakela J, Nowicki MJ, et al.: Hepatitis B virus core promoter sequence analysis in fulminant and chronic hepatitis B. Gastroenterology 1995, 109:1618–1623.PubMedCrossRefGoogle Scholar
  40. 40.
    Gunther S, Piwon N, Iwanska A, et al.: Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease. J Virol 1996, 70:8318–8331.PubMedGoogle Scholar
  41. 41.
    Baumert TF, Rogers SA, Hasegawa K, et al.: Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest 1996, 98:2268–2276.PubMedCrossRefGoogle Scholar
  42. 42.
    Akahane Y, Yamanaka T, Suzuki H, et al.: Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum. Disturbed synthesis and secretion of e antigen from hepatocytes due to a point mutation in the precore region. Gastroenterology 1990, 99:1113–1119.PubMedGoogle Scholar
  43. 43.
    Bonino F, Rosina F, Rizzetto M, et al.: Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. Gastroenterology 1986, 90(5 Pt 1):1268–1273.PubMedGoogle Scholar
  44. 44.
    Angus PW, Locarnini SA, McCaughan GW, et al.: Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation. Hepatology 1995, 21:14–18.PubMedCrossRefGoogle Scholar
  45. 45.
    Raimondo G, Meucci G, Sardo MA, et al.: Persistence of "wild-type" and "e-minus" hepatitis B virus infection in chronic healthy HBsAg/anti-HBe positive carriers. J Hepatol 1994, 20:148–151.PubMedCrossRefGoogle Scholar
  46. 46.
    Chu CM, Yeh CT, Lee CS, et al.: Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion. J Clin Microbiol 2002, 40:16–21.PubMedCrossRefGoogle Scholar
  47. 47.
    Zarski JP, Marcellin P, Cohard M, et al.: Comparison of anti-HBe-positive and HBe-antigen-positive chronic hepatitis B in France. French Multicentre Group. J Hepatol 1994, 20:636–640.PubMedCrossRefGoogle Scholar
  48. 48.
    Bonino F, Brunetto MR: Chronic hepatitis B e antigen (HBeAg) negative, anti-HBe positive hepatitis B: an overview. J Hepatol 2003, 39(suppl 1):S160-S163.PubMedCrossRefGoogle Scholar
  49. 49.
    Lamberts C, Nassal M, Velhagen I, et al.: Precore-mediated inhibition of hepatitis B virus progeny DNA synthesis. J Virol 1993, 67:3756–3762.PubMedGoogle Scholar
  50. 50.
    Brunetto MR, Oliveri F, Coco B, et al.: Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study. J Hepatol 2002, 36:263–270.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2006

Authors and Affiliations

  1. 1.Liver Diseases BranchNational Institutes of Diabetes and Digestive and Kidney DiseasesBethesdaUSA

Personalised recommendations